Targeted RNA Sequencing Market Research Report: Types, Volume, Revenue, Competitive Analysis, Benefits and lndustry Analysis 2023-2030
Targeted RNA Sequencing Market Overview:
The Targeted RNA Sequencing Market has demonstrated noteworthy growth, propelled by a rising
demand for accurate and efficient RNA molecule analysis. Positioned as an
advanced molecular biology technique, targeted RNA sequencing empowers
researchers to concentrate on specific RNA sequences of interest, delivering a
cost-effective and information-rich alternative to conventional methods.
Targeted RNA Sequencing Market was USD 4,554.59 million in 2022 It is projected
to reach USD 8,684.17 million by 2030, indicating a CAGR of 8.5% during the
forecast period.
Market Segmentation:
Targeted RNA
Sequencing Market can be segmented By Technology (Exome Sequencing, Enrichment
Sequencing, and Amplicon Sequencing), By Application (Biomedical Research,
Plant & Animal Sciences, Drug Discovery, and Others), By End-User (Academic
Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others), By
Region (North America, Europe, Asia-Pacific, Latin America, and Middle East
& Africa)
Market Key Drivers:
The robust Growth
of The Targeted RNA Sequencing Market is
underpinned by several key drivers. There is a discernible uptick in the importance
placed on comprehending gene expression patterns, splicing variants, and RNA
modifications. The method's capacity to provide valuable insights into disease
mechanisms, biomarker identification, and the facilitation of targeted
therapeutics development has driven its widespread adoption in both academic
and clinical settings.
Top
Key Players in the Targeted RNA Sequencing Market:
·
Roche
Holdings
·
Thermo
Fisher Scientific
·
Illumina
Inc.
·
Agilent
Technologies
·
Oxford
Nanopore Technologies
·
DNASTAR
Inc.
·
QIAGEN
·
BGI
·
Bio-Rad
Laboratories Inc.
·
PierianDx
Regional Analysis:
The foremost share
contribution to market
trends was observed in North
America, attributed to the substantial presence of key healthcare research
entities and a well-established healthcare industry. The growth in this region
is propelled by escalating investments in initiatives focusing on new drug
development, the expansion of hospital facilities, and other pertinent factors.
Notably, technological advancements and the heightened demand for innovative drugs
are acting as catalysts for market expansion in North America. This dynamic
confluence of factors underscores the region's pivotal role in shaping and
driving the growth trajectory of the market.
About Us:
Consegic
Business Intelligence Pvt Ltd. is the leading research industry that offers
contextual and data-centric research services to its customers across the
globe. The firm assists its clients to strategize business policies and
accomplish sustainable growth in their respective market domains. The industry
provides consulting services, syndicated research reports, and customized
research reports.
Topnotch
research organizations and institutions to comprehend the regional and global
commercial status use the data produced by Consegic Business Intelligence Pvt
Ltd. Our reports comprise in-depth analytical and statistical analysis on
various industries in foremost countries around the globe.
Contact us:
Consegic Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com
Comments
Post a Comment